Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
COVID-19
SARS-CoV-2
coronavirus
Journal
Journal of evidence-based integrative medicine
ISSN: 2515-690X
Titre abrégé: J Evid Based Integr Med
Pays: United States
ID NLM: 101719675
Informations de publication
Date de publication:
Historique:
entrez:
20
6
2020
pubmed:
20
6
2020
medline:
1
7
2020
Statut:
ppublish
Résumé
The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the development of such treatment, pharmaceutical companies and government agencies are currently testing several existing drugs for their effect on the virus. Gene-Eden-VIR and Novirin are natural, broad-spectrum, antiviral treatments proven to be safe and effective in several clinical studies. In this article, we present evidence indicating that the 5 Gene-Eden-VIR/Novirin ingredients have anti-betacoronavirus, and specifically, anti-SARS-CoV effects. We consider this evidence as a first indication of the anti-coronavirus effects of Gene-Eden-VIR/Novirin. Next, we are planning to conduct a clinical study with users of the treatments to test the effects of Gene-Eden-VIR/Novirin on individuals at risk and those infected with the virus.
Identifiants
pubmed: 32551855
doi: 10.1177/2515690X20932523
pmc: PMC7303500
doi:
Substances chimiques
Antiviral Agents
0
Drug Combinations
0
Gene-Eden-VIR
0
Plant Extracts
0
Quercetin
9IKM0I5T1E
Selenium
H6241UJ22B
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2515690X20932523Références
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18806269
pubmed: 30362389
Clin Transl Med. 2016 Dec;5(1):40
pubmed: 27766602
Nat Med. 2020 Apr;26(4):453-455
pubmed: 32284614
J Med Virol. 2020 May;92(5):522-528
pubmed: 32027036
Chin Med. 2010 Apr 06;5:13
pubmed: 20370896
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
J Enzyme Inhib Med Chem. 2017 Dec;32(1):504-515
pubmed: 28112000
J Korean Med Sci. 2020 Feb 17;35(6):e79
pubmed: 32056407
Mol Nutr Food Res. 2008 Nov;52(11):1273-80
pubmed: 18384097
Int J Infect Dis. 2020 Mar;92:214-217
pubmed: 32007643
Viruses. 2015 Dec 25;8(1):
pubmed: 26712783
Biotechnol Lett. 2012 May;34(5):831-8
pubmed: 22350287
Molecules. 2016 Apr 04;21(4):450
pubmed: 27049378
Drug Des Devel Ther. 2017 Mar 03;11:575-583
pubmed: 28424535
Nutrients. 2019 Sep 04;11(9):
pubmed: 31487871
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Ethnopharmacol. 2013 May 20;147(2):321-6
pubmed: 23518419
Phytother Res. 2006 Aug;20(8):687-95
pubmed: 16807880
J Virol. 2004 Oct;78(20):11334-9
pubmed: 15452254
Acta Oncol. 2010 Apr;49(3):397-9
pubmed: 20059310
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
Pharmacogn Mag. 2010 Jan;6(21):26-33
pubmed: 20548933
Pharmacogn Rev. 2016 Jul-Dec;10(20):84-89
pubmed: 28082789
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Antiviral Res. 2009 Apr;82(1):73-81
pubmed: 19428598
Biol Trace Elem Res. 2011 Dec;143(3):1325-36
pubmed: 21318622
Clin Nutr. 2017 Apr;36(2):407-415
pubmed: 26803169
J Microbiol Biotechnol. 2016 Jan;26(1):151-9
pubmed: 26403820
Lancet. 2003 Jun 14;361(9374):2045-6
pubmed: 12814717
Acta Pharm Sin B. 2015 Jul;5(4):310-5
pubmed: 26579460
Front Immunol. 2019 Jan 31;10:51
pubmed: 30766532
J Nutr. 2003 May;133(5 Suppl 1):1463S-7S
pubmed: 12730444
J Med Chem. 2005 Feb 24;48(4):1256-9
pubmed: 15715493
Molecules. 2017 Aug 12;22(8):
pubmed: 28805687
Adv Nutr. 2015 Jan 15;6(1):73-82
pubmed: 25593145
J Nutr. 1997 May;127(5 Suppl):958S-961S
pubmed: 9164273